期刊文献+

上海市儿童肠道病毒71型灭活疫苗接种率和疑似预防接种异常反应监测 被引量:20

Surveillance for coverage of inactivated enterovirus 71(EV71) vaccine and adverse events following immunization with EV71 vaccine among children in Shanghai
原文传递
导出
摘要 目的了解上海市肠道病毒71型(EV71)灭活疫苗接种率和疑似预防接种异常反应(AEFI)发生率。方法通过上海市免疫规划信息系统、中国AEFI监测信息管理系统收集2013年10月-2019年3月出生儿童EV71疫苗接种和AEFI数据,分析EV71疫苗接种率和AEFI发生率。结果上海市2013年10月-2019年3月出生儿童EV71疫苗1剂次接种率为38.30%,2剂次(全程)接种率为35.05%。本市、外来人口1剂次接种率分别为46.34%、33.89%,2剂次接种率分别为43.61%、30.36%;各年龄组1剂次接种率在20.49%-52.71%之间,2剂次接种率在17.34%-49.85%之间。EV71疫苗接种后AEFI报告发生率为224.91/10万剂(3046例);其中一般反应、异常反应分别为217.08/10万剂(2940例)、6.87/10万剂(93例),分别以发热(2263例,167.09/10万剂)、过敏性皮疹(87例,6.42/10万剂)为主。结论上海市儿童EV71疫苗接种率不高,AEFI报告发生率在预期范围内;仍应加强EV71疫苗接种宣传,提高儿童接种率。 Objective To analyze coverage of inactivated enterovirus 71(EV71)vaccine and incidence of adverse events following immunization(AEFIs)with EV71 vaccine among children in Shanghai.Methods We collected data on EV71 vaccination and AEFI cases among children born from October 2013 to March 2019 and reported to the Shanghai Immunization Information Management System and the China AEFI Information Management System;we assessed EV71 vaccine coverage and AEFI incidence.Results Coverage rates for one dose and two doses of EV71 vaccine were 38.30%and 35.05%,respectively,among children born from October 2013 to March 2019.Coverage rates for one dose of EV71 vaccine were 46.34%and 33.89%among local and migrant children,and coverage levels for two doses were 43.61%and 30.36%among local and migrant children,respectively.Coverage rates by age for one dose of EV71 vaccine ranged from 20.49%to 52.71%;coverage for two doses ranged f rom 17.34%to 49.85%.The reported EV71 vaccine AEFI incidence was 224.91 cases per 100000 doses(3046 cases total)with 217.08 per 100000(2940 cases)for common adverse reactions and 6.87 per 100000(93 cases)for rare adverse reactions;most common adverse reactions were fever(2263 cases,167.09 per 100000)and most rare adverse reactions were allergic rash(87 cases,6.42 per 100000).Conclusions Coverage of EV71 vaccination was not high among children in Shanghai,and the AEFI incidence of EV71 vaccine was not higher than the expected.We should strengthen health education to improve use of EV71 vaccine among children.
作者 吴琳琳 刘捷宸 邵慧勇 孙晓冬 Wu Linlin;Liu Jiechen;Shao Huiyong;Sun Xiaodong(Shanghai Municipal Center for Disease Control and Prevention,Shanghai 200336,China)
出处 《中国疫苗和免疫》 北大核心 2020年第1期62-66,81,共6页 Chinese Journal of Vaccines and Immunization
基金 上海市卫生和计划生育委员会科研课题(20184Y0243).
关键词 肠道病毒71型灭活疫苗 接种率 疑似预防接种异常反应 监测 Inactivated enterovirus 71 vaccine Coverage Adverse event following immunization Surveillance
  • 相关文献

参考文献9

二级参考文献110

  • 1黄清臻,邵新玺,周广平.气候变暖对传染病的影响[J].医学动物防制,2000,16(2):110-112. 被引量:33
  • 2胡亚美,诸福堂.实用儿科学[M].7版.北京:人民卫生出版社,2002:1174
  • 3中国疾病预防控制中心.法定传染病报告[EB/OL].(2013-03-27)[2013-10-12].http://www.chinacdc.cn/tjsj/fdcrbbg/.
  • 4Zhu FC,Meng FY,Li JX,et al. Efficacy,safety ,and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial[ J]. Lancet,2013,381 (9882) :2024 -2032.
  • 5Zhu F, Xu W, Xia J, et al, Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China[ J]. N Engl J Med,2014, 370(9) :818 -828.
  • 6Li RC, Liu LD, Mo Z J, et al. An inactivated enterovirus 71 vac- cine in healthy children [ J ]. N Engl J Med, 2014,370 ( 9 ) : 829 - 837.
  • 7Alexander JP Jr, Baden L, Pallansch MA, et al. Enterovirus 71 in- fection and nearologic disease-United States, 1977-1991 [J]. J In- fect Dis, 1994, 169(4) : 905-908.
  • 8Guan D, Vander Sanden S, Zeng H, et al. Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Main-land China, 1998-2010IJ1. PLoS One, 2012, 7(9) : e44386.
  • 9Zhang Y, Tan X, Cui A, et al. Complete genome analysis of the C4 subgenotype strains of enterovirus 71 : predominant recombina- tion C4 viruses persistently circulating in China for 14 years[ J]. PLoS One, 2013, 8(2) : e56341.
  • 10Chang LY, Huang YC, Lin TY. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease [ J]. Lancet, 1998, 352(9125) : 367-368.

共引文献336

同被引文献230

引证文献20

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部